Current status on microRNAs as biomarkers for ovarian cancer

APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
Kira Philipsen PrahmEstrid Høgdall

Abstract

Ovarian cancer (OC) is the most lethal gynecological malignancy in the Western world, and has a very poor prognosis, often due to late diagnosis and emergence of chemotherapy resistance. Therefore, there is an essential need for new diagnostic and prognostic markers that can improve and initiate more personalized treatment, eventually improving survival of the patients. MicroRNAs are small, non-coding RNA molecules, that post-transcriptionally regulate gene expression. Several studies have within the last decade shown that microRNAs are deregulated in OC and have potential as diagnostic and prognostic biomarkers for OC. Recently studies have also focused on microRNAs as predictors of chemotherapy responses and their potential as therapeutic targets. However, many of the published studies are difficult to interpret as a whole due to various methods of analysis. Future focus should be aimed at developing a general standardized analytical method, which can limit differences between studies thus allowing easier comparison across them. In addition, validation of studies in independent series that ideally should be histotype-specific is essential to determine the clinical role of microRNAs in different types of OC. In this review we ...Continue Reading

References

Mar 8, 2000·The Oncologist·M Markman, M A Bookman
Nov 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·George Adrian CalinCarlo M Croce
Dec 19, 2003·Nucleic Acids Research·Sam Griffiths-Jones
Dec 31, 2003·Cell·Benjamin P LewisChristopher B Burge
Dec 22, 2004·Molecular Cell·Bryan R Cullen
Feb 23, 2005·Cancer Science·Yoko KarubeTakashi Takahashi
Mar 16, 2005·Cell·Steven M JohnsonFrank J Slack
Jun 10, 2005·Nature·Jun LuTodd R Golub
Jan 6, 2006·The New England Journal of Medicine·Deborah K ArmstrongUNKNOWN Gynecologic Oncology Group
Jun 30, 2007·Proceedings of the National Academy of Sciences of the United States of America·Scott ShellMarcus E Peter
Aug 19, 2007·Cancer Research·Charles D JohnsonFrank J Slack
Aug 29, 2007·The American Journal of Pathology·Wenyong ZhangWayne Tam
Sep 19, 2007·Cancer Research·Marilena V IorioCarlo M Croce
Mar 11, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Richard J FlavinJohn J O'Leary
May 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eun Ji NamSunghoon Kim
May 7, 2008·Proceedings of the National Academy of Sciences of the United States of America·Lin ZhangGeorge Coukos
Jul 1, 2008·Gynecologic Oncology·Douglas D Taylor, Cicek Gercel-Taylor
Aug 5, 2008·Trends in Molecular Medicine·Ingo BüssingHelge Grosshans
Sep 9, 2008·Trends in Cell Biology·Sarah Roush, Frank J Slack
Oct 1, 2008·Gynecologic Oncology·Antonio SorrentinoCristiano Ferlini
Dec 19, 2008·The New England Journal of Medicine·William M MerrittAnil K Sood
Feb 28, 2009·Clinical Chemistry·Claudine L Bartels, Gregory J Tsongalis
Apr 4, 2009·The Journal of Biological Chemistry·Ashley J Pratt, Ian J MacRae
May 14, 2009·Molecular Cancer Therapeutics·Dawn R CochraneJennifer K Richer
Jun 3, 2009·The Journal of Clinical Investigation·Raghu Kalluri
Jun 9, 2009·Gynecologic Oncology·Xiaoxia HuXiaowei Wang
Nov 3, 2009·Neoplasia : an International Journal for Oncology Research·Karen D Cowden DahlLaurie G Hudson
Feb 11, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David C CorneyAlexander Yu Nikitin
Feb 27, 2010·Journal of Surgical Oncology·Lori E WeinbergJean A Hurteau
Jul 29, 2010·Cancer Research·Derek M Dykxhoorn
Aug 5, 2010·British Journal of Cancer·S F M HäuslerJ Wischhusen

❮ Previous
Next ❯

Citations

Aug 2, 2016·BioMed Research International·Li-Wei LiuQiang Wang
Oct 4, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ahmad Mahdian-ShakibNavid Saidi
Sep 17, 2016·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Tao ZhuShihua Wang
Apr 28, 2017·Biomolecular Concepts·Virginie Armand-Labit, Anne Pradines
Mar 24, 2018·Artificial Cells, Nanomedicine, and Biotechnology·Leila KafshdoozSamaneh Ghasemali
Dec 27, 2018·Archives of Gynecology and Obstetrics·Dominik BiegIlona Bednarek
Nov 19, 2019·PloS One·Douglas Nogueira Perez OliveiraEstrid V Høgdall
May 5, 2017·Expert Review of Molecular Diagnostics·Wei-Lei YangRobert C Bast
May 1, 2021·International Journal of Molecular Sciences·Riccardo Di FioreJean Calleja-Agius

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Molecular and Cellular Endocrinology
Marta LlauradóMarina Rigau
Human Pathology
Betina KatzBen Davidson
European Journal of Haematology
Konstantinos DimopoulosKirsten Grønbæk
© 2021 Meta ULC. All rights reserved